REG - EMV Capital PLC - Result of AGM

EMV CapitalAnnouncement

30/06/2025 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nRSd0094Pa&default-theme=true

RNS Number : 0094P  EMV Capital PLC  30 June 2025

For immediate release

 

EMV Capital plc

 

("EMVC" or the "Company")

 

Result of Annual General Meeting

 

EMV Capital Plc (AIM: EMVC), the deep tech and life sciences VC investment
group, announces that all resolutions set out in the 2025 Notice of Annual
General Meeting sent to shareholders were duly passed at the Company's Annual
General Meeting held earlier today.

Result of Annual General Meeting

 

Resolutions 1 to 9 were passed as Ordinary Resolutions and Resolution 10 was
passed as a Special Resolution. The proxy voting results are as follows:

 

 Resolution                                                                      For        %       Against  %     Vote Total  Vote Total as % of Issued Share Capital  Withheld*
 1.    To receive and adopt the Company's Annual Report and Accounts for the     8,703,874  100.0%  1,617    0.0%  8,705,491   31.4%                                    266
 period ended 31 December 2024

 2.    To receive and approve the Directors' Remuneration Report                 8,585,144  98.8%   106,993  1.2%  8,692,137   31.3%                                    13,620

 3.    To reappoint BDO LLP as the auditors for the forthcoming year             8,696,626  99.9%   8,865    0.1%  8,705,491   31.4%                                    266

 4.    To authorise the Audit Committee in determining the Auditors'             8,694,933  100.0%  2,558    0.0%  8,697,491   31.3%                                    8,266
 remuneration

 5.    To confirm the reappointment of Dr Charles Spicer as a director           8,689,567  99.9%   6,617    0.1%  8,696,184   31.3%                                    9,573

 6.    To confirm the reappointment of Dr Ilian Iliev as a director              8,689,567  99.9%   6,617    0.1%  8,696,184   31.3%                                    9,573

 7.    To confirm the reappointment of Edward Hooper as a director               8,689,567  99.9%   6,617    0.1%  8,696,184   31.3%                                    9,573

 8.    To confirm the reappointment of Dr Jonathan Robinson as a director        8,689,567  99.9%   6,617    0.1%  8,696,184   31.3%                                    9,573

 9.    To authorise the Directors to allot relevant securities pursuant to       8,178,221  95.2%   414,852  4.8%  8,593,073   30.9%                                    112,684
 section 551 of the Companies Act 2006

 10.  To disapply pre-emption rights on the allotment of securities or sale of   8,233,170  94.7%   456,228  5.3%  8,689,398   31.3%                                    16,359
 treasury shares in connection with a pre-emptive offer or on allotment of up
 to 5,553,460 shares

 

* A vote withheld is not a vote in law and is not counted in the calculation
of the proportion of votes "For" or "Against" a resolution.

 

 

For more information, please contact:

 EMV Capital plc                                                              via Rosewood

 Ilian Iliev, CEO

 Panmure Liberum Limited (NOMAD and Broker)                                   +44 (0)20 7886 2500

 Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Rosewood (Financial PR)                                                      +44 (0)20 7653 8702
 John West / Llewellyn Angus / Lily Pearce

 

About EMV Capital plc (EMVC)

 

EMV Capital plc, is a deep tech and life sciences venture capital investment
group with an international portfolio of high-growth companies.

With a strategic focus on generating superior returns for investors from the
fast-growing sectors and technologies that will define our future; EMV Capital
invests in, manages and strengthens early-stage IP-rich companies.

EMV Capital holds both direct equity stakes and carried interest in its
portfolio companies, creating an evergreen structure that supports extensive
growth and value creation. EMV Capital's investment thesis is realised through
these capital sources:

·     capital-efficient investments through Group balance sheet;

·     fund management of the Evergreen EIS and Martlet Capital Funds;

·     syndicated investments leveraging its network of third-party
investors.

EMV Capital's approach is characterised by its proactive management style,
aiming to advance portfolio companies to critical value inflection points by
actively engaging with them. Companies are supported through Board
representation and the use of its Value Creation Services practice.

Headquartered in London, with a Cambridge presence and strong international
links, EMV Capital is quoted on the AIM market of the London Stock Exchange.

www.emvcapital.com (http://www.emvcapital.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGWPUGPQUPAGGU